BioLife announces the launch of its first line of cannabinoid consumer products including six new tincture formulations.
BioLife announces the launch of its first line of cannabinoid consumer products including six new tincture formulations.
BioLife Sciences Inc. announced it has successfully received qualification of its Form 1-A with the SEC to raise up to $20,000,000
BioLife announced today that it has filed Form 1-A with the Securities and Exchange Commission (SEC) seeking to raise up to $20 million under a Tier 1…
BioLife announced today the launch of Copper Infused Gardening Gloves. These Copper Infused Gardening Gloves are the Company’s latest addition to their…
BioLife is pleased to announce that it is now going to offer non-psychoactive cannabinoid products derived from industrial hemp including CBD products.
BioLife announced the launch of their new antimicrobial copper-infused fabric pot. The BioLife Copper Fabric Pot is the first product being added to…
BioLife is pleased to announce the launching of a new life sciences division, aimed at honing in on disruptive technology and solutions with a focus on
BioLife Sciences is pleased to announce that it has finalized an agreement with Health Box LLC towards the 100% acquisition of the Arizona-based company.
BioLife is pleased to announce that it has entered into exclusive negotiations with Health Box LLC, an Arizona-based company which provides a diverse mix of…
BioLife Sciences announced the appointment of new board members and officers, effective as of December 1st, 2020. BioLife welcomes distinguished….
BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors.
2831 Saint Rose Parkway Suite 200 Henderson, NV 89052 United States
Copyright © 2022 BioLife Sciences Inc. All Rights Reserved.
